Page last updated: 2024-08-24

capecitabine and Endocrine Gland Neoplasms

capecitabine has been researched along with Endocrine Gland Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koshida, Y; Mukai, K; Nishi, T; Shimoyama, Y; Toriumi, F; Yamamoto, T; Yamanashi, T	1
Aaron, M; Halperin, DM; Hoff, AO; Hoff, PM; Phan, AT; Yao, JC	1
Brayshaw, PA; Claringbold, PG; Price, RA; Turner, JH	1

Trials

2 trial(s) available for capecitabine and Endocrine Gland Neoplasms

Article	Year
A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers. BMC cancer, 2014, Aug-02, Volume: 14 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Capecitabine; Dacarbazine; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Endocrine Gland Neoplasms; Female; Fluorouracil; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pyrimidines; Treatment Outcome	2014
Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Capecitabine; Deoxycytidine; Disease Progression; Endocrine Gland Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Pilot Projects; Radiometry; Salvage Therapy; Treatment Outcome	2011

Article

Year

A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers.

BMC cancer, 2014, Aug-02, Volume: 14

Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Capecitabine; Dacarbazine; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Endocrine Gland Neoplasms; Female; Fluorouracil; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pyrimidines; Treatment Outcome

2014

Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours.

European journal of nuclear medicine and molecular imaging, 2011, Volume: 38, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Capecitabine; Deoxycytidine; Disease Progression; Endocrine Gland Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Octreotide; Pilot Projects; Radiometry; Salvage Therapy; Treatment Outcome

2011

Other Studies

1 other study(ies) available for capecitabine and Endocrine Gland Neoplasms

Article	Year
[A case of endocrine cell carcinoma of the ascending colon with liver metastasis treated with hepatectomy after excision of the primary lesion and systemic chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:1 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colon, Ascending; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Endocrine Gland Neoplasms; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Oxaliplatin	2014

Article

Year

[A case of endocrine cell carcinoma of the ascending colon with liver metastasis treated with hepatectomy after excision of the primary lesion and systemic chemotherapy].

Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:1

Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colon, Ascending; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Endocrine Gland Neoplasms; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Male; Organoplatinum Compounds; Oxaliplatin

2014